Echirolles Cedex Service de Medecine Interne and Pharmacie Centrale, Lille Cedex; Serge Perrot, MD PhD, essais cliniques and Service de Rhumatologie-Unite de recherche clinique P.R.E.D.O. S, Amiens Cedex ,
Servicio de Reumatologia and Servicio de Farmacia Planta Sotano, Pabellon A, Hospital Universitario Carlos Haya, Pabellon Hospital Civil, Malaga; Juan Gómez-Reino, MD, PhD, Servicio de Reumatologia Hospital Clinico and Servicio de Farmacia, planta-4 Hospital, de Reumatologia Hospital Central de Asturias and Servicio de Farmacia, planta -4 Hospital Central de Asturias ,
Newcastle upon Tyne United States: Patrick Fatigue Consultation Clinic, Oregon Health & Science University Research and OHSU Research PharmacyPinnacle Research ,
Inc, at Great Lakes Family Care Cardillac ,
Advanced Clinical Research Institute Victor Rosenfeld, MD, Sansum Clinic and Sleep Med-Encina Lodge Apex Research Institute, MD (Initial PI was Robert Schreiman, MD) ,
Author details 1, Northridge Neurological Research ,
The american college of rheumatology 1990 criteria for the classification of fibromyalgia, Rheumatology 1990 criteria for the classification of fibromyalgia: report of the Multicenter Criteria Committee, pp.160-172, 1990. ,
DOI : 10.1002/art.1780330203
The American College of Rheumatology Preliminary Diagnostic Criteria for Fibromyalgia and Measurement of Symptom Severity, Arthritis Care & Research, vol.68, issue.Suppl, pp.600-610, 2010. ,
DOI : 10.1002/acr.20140
Fibromyalgia Syndrome: Canadian Clinical Working Case Definition, Diagnostic and Treatment Protocols???A Consensus Document, Journal of Musculoskeletal Pain, vol.11, issue.4, pp.3-107, 2003. ,
DOI : 10.1300/J094v11n04_02
The prevalence and characteristics of fibromyalgia in the general population, Arthritis & Rheumatism, vol.14, issue.Suppl 9, pp.19-28, 1995. ,
DOI : 10.1002/art.1780380104
Health status and disease severity in fibromyalgia. Results of a six-center longitudinal study, Arthritis & Rheumatism, vol.23, issue.9, pp.1571-1579, 1997. ,
DOI : 10.1002/art.1780400905
Fibromialgia: enfermedad de la emoci??n o emoci??n del dolor, Medicina Cl??nica, vol.131, issue.13, pp.503-504, 2008. ,
DOI : 10.1157/13127286
Fibromyalgia Syndrome Module at OMERACT 9: Domain Construct, The Journal of Rheumatology, vol.36, issue.10, pp.2318-2329, 2009. ,
DOI : 10.3899/jrheum.090367
Key Symptom Domains to Be Assessed in Fibromyalgia (Outcome Measures in Rheumatoid Arthritis Clinical Trials), Rheumatic Disease Clinics of North America, vol.35, issue.2 ,
DOI : 10.1016/j.rdc.2009.05.002
Development and validation of the Fibromyalgia Rapid Screening Tool (FiRST), Pain, vol.150, issue.2, pp.250-256, 2010. ,
DOI : 10.1016/j.pain.2010.03.034
Safety Profile and Tolerability of Up to 1 Year of Pregabalin Treatment in 3 Open-Label Extension Studies in Patients With Fibromyalgia, Clinical Therapeutics, vol.34, issue.5, pp.1092-1102, 2012. ,
DOI : 10.1016/j.clinthera.2012.03.003
Longterm Therapeutic Response to Milnacipran Treatment for Fibromyalgia. A European 1-Year Extension Study Following a 3-Month Study, The Journal of Rheumatology, vol.38, issue.7, pp.1403-1412, 2011. ,
DOI : 10.3899/jrheum.101025
A 1-year Safety and Efficacy Study of Duloxetine in Patients With Fibromyalgia, The Clinical Journal of Pain, vol.25, issue.5, pp.365-375, 2009. ,
DOI : 10.1097/AJP.0b013e31819be587
Long-Term Safety, Tolerability, and Efficacy of Duloxetine in the Treatment of Fibromyalgia, Seminars in Arthritis and Rheumatism, vol.39, issue.6, pp.454-464, 2010. ,
DOI : 10.1016/j.semarthrit.2008.11.001
Durability of Therapeutic Response to Milnacipran Treatment for Fibromyalgia. Results of a Randomized, Double-Blind, Monotherapy 6-Month Extension Study, Pain Medicine, vol.11, issue.2, pp.180-194, 2010. ,
DOI : 10.1111/j.1526-4637.2009.00755.x
Guidelines on the management of fibromyalgia syndrome - A systematic review, European Journal of Pain, vol.40, issue.57, pp.5-10, 2010. ,
DOI : 10.1016/j.ejpain.2009.01.006
Comparative efficacy and acceptability of amitriptyline, duloxetine and milnacipran in fibromyalgia syndrome: a systematic review with meta-analysis, Rheumatology, vol.50, issue.3, pp.532-543, 2011. ,
DOI : 10.1093/rheumatology/keq354
Amitriptyline in the treatment of fibromyalgia: a systematic review of its efficacy, Rheumatology, vol.47, issue.12, pp.1741-1746, 2008. ,
DOI : 10.1093/rheumatology/ken317
Comparative Efficacy and Harms of Duloxetine, Milnacipran, and Pregabalin in Fibromyalgia Syndrome, The Journal of Pain, vol.11, issue.6, pp.505-521, 2007. ,
DOI : 10.1016/j.jpain.2010.01.002
Serotonin and noradrenaline reuptake inhibitors (SNRIs) for fibromyalgia syndrome, Cochrane Database Syst Rev, vol.10, issue.8, p.10292, 2013. ,
DOI : 10.1002/14651858.CD010292
The Longitudinal Outcome of Fibromyalgia: A Study of 1555 Patients, The Journal of Rheumatology, vol.38, issue.10, pp.2238-2246, 2011. ,
DOI : 10.3899/jrheum.110026
The nightly administration of sodium oxybate results in significant reduction in the nocturnal sleep disruption of patients with narcolepsy, Sleep Medicine, vol.10, issue.8, pp.829-835, 2009. ,
DOI : 10.1016/j.sleep.2009.05.004
The nightly use of sodium oxybate is associated with a reduction in nocturnal sleep disruption: a double-blind, placebo-controlled study in patients with narcolepsy, J Clin Sleep Med, vol.6, pp.596-602, 2010. ,
Effects of Sodium Oxybate on Sleep Physiology and Sleep/Wake-related Symptoms in Patients with Fibromyalgia Syndrome: A Double-blind, Randomized, Placebo-controlled Study, The Journal of Rheumatology, vol.37, issue.10, pp.2156-2166, 2010. ,
DOI : 10.3899/jrheum.091041
Sodium oxybate relieves pain and improves function in fibromyalgia syndrome: A randomized, double-blind, placebo-controlled, multicenter clinical trial, Arthritis & Rheumatism, vol.40, issue.1, pp.299-309, 2009. ,
DOI : 10.1002/art.24142
Sodium Oxybate in Fibromyalgia 06?009 Study Group: The effects of sodium oxybate on sleep disturbance, fatigue, and functioning in fibromyalgia: results from a phase 3, randomized, double-blind, placebo-controlled international trial [abstract], Ann Rheum Dis, vol.69, p.449, 2010. ,
Sodium oxybate reduces pain, fatigue, and sleep disturbance and improves functionality in fibromyalgia: Results from a 14-week, randomized, double-blind, placebo-controlled study, Pain, vol.152, issue.5, pp.1007-1017, 2011. ,
DOI : 10.1016/j.pain.2010.12.022
Sodium oxybate therapy provides multidimensional improvement in fibromyalgia: results of an international phase 3 trial, Annals of the Rheumatic Diseases, vol.71, issue.6, pp.935-942, 2012. ,
DOI : 10.1136/annrheumdis-2011-200418
Core outcome measures for chronic pain clinical trials: IMMPACT recommendations, Pain, vol.113, issue.1, pp.9-19, 2005. ,
DOI : 10.1016/j.pain.2004.09.012
Minimal Clinically Important Difference in the Fibromyalgia Impact Questionnaire, The Journal of Rheumatology, vol.36, issue.6, pp.1304-1311, 2009. ,
DOI : 10.3899/jrheum.081090
The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10, J Clin Psychiatry, vol.59, pp.22-33, 1998. ,
San Antonio: The Psychological Corporation, 1996. ,
The fibromyalgia impact questionnaire: development and validation, pp.728-733, 1991. ,
ECDEU Assessment Manual for Psychopharmacology, Revised. US Department of Health, Education, and Welfare publication ,
The MOS 36-ltem Short-Form Health Survey (SF-36), Medical Care, vol.30, issue.6, pp.473-483, 1992. ,
DOI : 10.1097/00005650-199206000-00002
An instrument to measure functional status outcomes for disorders of excessive sleepiness, pp.835-843, 1997. ,
Illicit gamma-hydroxybutyrate (GHB) and pharmaceutical sodium oxybate (Xyrem??): Differences in characteristics and misuse, Drug and Alcohol Dependence, vol.104, issue.1-2, pp.1-10, 2009. ,
DOI : 10.1016/j.drugalcdep.2009.04.012
Assessing depression in fibromyalgia patients, Arthritis Care & Research, vol.239, issue.1, pp.35-39, 1994. ,
DOI : 10.1002/art.1790070108
Major depression, fibromyalgia and labour force participation: A population-based cross-sectional study, BMC Musculoskeletal Disorders, vol.17, issue.1, 2006. ,
DOI : 10.1016/S1521-6942(03)00034-2
Mortality in a cohort of Danish patients with fibromyalgia: Increased frequency of suicide, Arthritis & Rheumatism, vol.61, issue.Suppl 9, pp.3101-3108, 2010. ,
DOI : 10.1002/art.27623
Suicide attempts and risk of suicide in patients with fibromyalgia: a survey in Spanish patients, Rheumatology, vol.50, issue.10, pp.1889-1893, 2011. ,
DOI : 10.1093/rheumatology/ker203
Mortality in fibromyalgia: A study of 8,186 patients over thirty-five years, Arthritis Care & Research, vol.341, issue.Suppl 51, pp.94-101, 2011. ,
DOI : 10.1002/acr.20301
Weight loss in narcolepsy patients treated with sodium oxybate, Sleep Medicine, vol.10, issue.6, pp.661-663, 2009. ,
DOI : 10.1016/j.sleep.2008.05.012
The Clinical Importance of Changes in the 0 to 10 Numeric Rating Scale for Worst, Least, and Average Pain Intensity: Analyses of Data from Clinical Trials of Duloxetine in Pain Disorders, The Journal of Pain, vol.11, issue.2, pp.109-118, 2010. ,
DOI : 10.1016/j.jpain.2009.06.007
Efficacy and safety of milnacipran 100 mg/day in patients with fibromyalgia: Results of a randomized, double-blind, placebo-controlled trial, Arthritis & Rheumatism, vol.11, issue.Suppl 2, pp.2745-2756, 2010. ,
DOI : 10.1002/art.27559
A European Multicenter Randomized Double-blind Placebo-controlled Monotherapy Clinical Trial of Milnacipran in Treatment of Fibromyalgia, The Journal of Rheumatology, vol.37, issue.4, pp.851-859, 2010. ,
DOI : 10.3899/jrheum.090884
Milnacipran for the treatment of fibromyalgia in adults: A 15-week, multicenter, randomized, double-blind, placebo-controlled, multiple-dose clinical trial, Clinical Therapeutics, vol.30, issue.11, pp.1988-2004, 2008. ,
DOI : 10.1016/j.clinthera.2008.11.009
A Pooled Analysis of Two Randomized, Double-Blind, Placebo-Controlled Trials of Milnacipran Monotherapy in the Treatment of Fibromyalgia, Pain Practice, vol.60, issue.10, pp.120-131, 2011. ,
DOI : 10.1111/j.1533-2500.2010.00403.x
The Efficacy and Safety of Milnacipran for Treatment of Fibromyalgia. A Randomized, Double-blind, Placebo-controlled Trial, The Journal of Rheumatology, vol.36, issue.2, pp.398-409, 2009. ,
DOI : 10.3899/jrheum.080734